✦ LIBER ✦

Progress and problems in screening for carcinoma of the prostate

✍ Scribed by Gerald W. Chodak; Harry W. Schoenberg

Publisher: Springer
Year: 1989
Tongue: English
Weight: 580 KB
Volume: 13
Category: Article
ISSN: 0364-2313
DOI: 10.1007/bf01671155

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Screening for carcinoma of the prostate

✍ Alexander, Freda E. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 2 views

Screening for carcinoma of the prostate:

Screening for carcinoma of the prostate: Efficacy of available screening tests

✍ Ian M. Thompson; William R. Fair 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 683 KB

Dedifferentiation in the metastatic prog

Dedifferentiation in the metastatic progression of prostate carcinoma

✍ Liang Cheng; Jeff Slezak; Erik J. Bergstralh; John C. Cheville; Susan Sweat; Hor 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 2 views

## BACKGROUND. Dedifferentiation is a distinctive feature of cancer progression. Detailed histologic analysis of primary prostate carcinoma and synchronous lymph node metastases may improve our understanding of the complex process of cancer progression and metastasis. ## METHODS. The authors s

Expression of cathepsins B and S in the

Expression of cathepsins B and S in the progression of prostate carcinoma

✍ Pedro L. Fernández; Xavier Farré; Alfons Nadal; Eva Fernández; Nerea Peiró; Bonn 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 352 KB 👁 1 views

Prostate carcinoma screening in the coun

Prostate carcinoma screening in the county of Tyrol, Austria : Experience and results

✍ Andreas Reissigl; W. Horninger; K. Fink; H. Klocker; G. Bartsch 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Background: This article summarizes the experience and results of different prostate carcinoma screening projects using total prostate specific antigen (psa) as the initial test and different diagnostic tests to improve specificity. ## Methods: The seven projects studied included 1) a mass scr

High-dose calcitriol, zoledronate, and d

High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma

✍ Michael J. Morris; Oren Smaletz; David Solit; W. Kevin Kelly; Susan Slovin; Carl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract ## BACKGROUND Preclinical and clinical data have suggested that high‐dose calcitriol (1,25‐dihydroxycholecalciferol) has activity against prostate carcinoma. Pulse‐dosed calcitriol and dexamethasone may maximize tolerability and efficacy. The authors examined the toxicity of pulse‐dose